Longevity vs Aging: The 3 Biggest Paths Researchers Target Today
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
Instead of treating age-related diseases one by one, researchers are targeting aging itself—the shared root.
Three directions matter right now:
A) Senolytics: clearing senescent “zombie” cells that drive inflammation
B) Epigenetic reprogramming: restoring youthful gene regulation (software reset—precision is everything)
C) Metabolic & dietary signaling: activating survival programs (autophagy, DNA repair, lower inflammation) via CR mimetics like metformin, rapamycin, and NAD⁺ pathways
Comment: which approach feels most promising—and which feels most risky?
#Longevity #Aging #Senolytics #Epigenetics #Metformin #rapamycin
geneXplain · 3 min · Source published: 2026-01-30
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.